The FDA has approved Novartis Coartem Baby, the first malaria treatment designed for newborns and young infants. The medicine, developed in collaboration with Medicines for Malaria Venture, a nonprofit partnership, is intended for babies weighing less than 10 pounds, an age group previously left without an approved option, according to a July 8 news release […]
